Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Corticosteroids
1.4.3 Phosphodiesterase Type 4 Inhibitors
1.4.4 Bronchodilators
1.4.5 Others
1.5 Market by Application
1.5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Retail Pharmacies
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size
2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Growth Trends by Regions
2.2.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Regions (2019-2025)
2.2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by by Players
3.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by by Players (2014-2019)
3.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players Head office and Area Served
3.3 Key Players Chronic Obstructive Pulmonary Disease (COPD) Treatment Product/Solution/Service
3.4 Date of Enter into Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2014-2019)
4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
5.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in North America
5.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
5.4 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
6 Europe
6.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
6.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in Europe
6.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
6.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
7 China
7.1 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
7.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in China
7.3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
7.4 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
8 Japan
8.1 Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
8.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in Japan
8.3 Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
8.4 Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
9.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
9.4 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
10 India
10.1 India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
10.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in India
10.3 India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
10.4 India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
11.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in Central & South America
11.3 Central & South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
11.4 Central & South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.1.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019))
12.1.5 AstraZeneca Recent Development
12.2 Boehringer Ingelheim International GmbH
12.2.1 Boehringer Ingelheim International GmbH Company Details
12.2.2 Company Description and Business Overview
12.2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.2.4 Boehringer Ingelheim International GmbH Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.2.5 Boehringer Ingelheim International GmbH Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.3.4 GlaxoSmithKline Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Company Details
12.4.2 Company Description and Business Overview
12.4.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.4.4 Novartis AG Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.4.5 Novartis AG Recent Development
12.5 Teva Pharmaceutical Industries
12.5.1 Teva Pharmaceutical Industries Company Details
12.5.2 Company Description and Business Overview
12.5.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.5.4 Teva Pharmaceutical Industries Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.5.5 Teva Pharmaceutical Industries Recent Development
12.6 Sunovion Pharmaceuticals
12.6.1 Sunovion Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.6.4 Sunovion Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.6.5 Sunovion Pharmaceuticals Recent Development
12.7 CHIESI Farmaceutici
12.7.1 CHIESI Farmaceutici Company Details
12.7.2 Company Description and Business Overview
12.7.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.7.4 CHIESI Farmaceutici Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.7.5 CHIESI Farmaceutici Recent Development
12.8 Orion Corporation
12.8.1 Orion Corporation Company Details
12.8.2 Company Description and Business Overview
12.8.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.8.4 Orion Corporation Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.8.5 Orion Corporation Recent Development
12.9 Mylan
12.9.1 Mylan Company Details
12.9.2 Company Description and Business Overview
12.9.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.9.4 Mylan Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.9.5 Mylan Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
【掲載企業】
AstraZeneca、Boehringer Ingelheim International GmbH、GlaxoSmithKline、Novartis AG、Teva Pharmaceutical Industries、Sunovion Pharmaceuticals、CHIESI Farmaceutici、Orion Corporation、Mylan